Regeneron Q3'26 Earnings Preview: EPS Estimate 16.42 USD
Regeneron is scheduled to report Q3'26 results on October 30 before the market opens. Revenue is estimated at 4.56 billion USD, with EPS at 16.42 USD.
REGN (Regeneron Pharmaceuticals, Inc.) is set to announce its Q3'26 results on October 30, before the market opens. The earnings are expected to be disclosed at 6:30 AM ET (10:30 AM UTC).For Q3'26, revenue estimate is 4.56 billion USD with EPS (earnings per share) anticipated at 16.42 USD. Learn mo…